Chromodynamics funding news – Eindhoven-based Chromodynamics has Raised €2Million in Seed Funding

Wouter Vijvers, founder and CEO of Chromodynamics said, “It is really exciting to secure the funding needed to realise our vision, Over the past years, we have done so much market validation and technology development to prove that we have a winner in our hands. Now, we can enter the next phase. Our solution improves upon the state-of-the-art by an order of magnitude on all important performance metrics (throughput, ease-of-use, level of detail), while dramatically reducing costs for the customer,”.

KIKK Capital is a deep tech investor that helps startups build strong, sustainable businesses by providing funding and support to seize growth opportunities.

Read also - Taito.ai funding news - Helsinki-based Taito.ai has Secured €2.5 Million in Seed Funding

Johan Sebregts, Managing Partner at KIKK Capital said, “From the first meeting with Chromodynamics, we were impressed by the founders and their innovative solution addressing a significant challenge in the biotech industry. As a Deep Tech investor and experienced investor in biotech platform technology, we are well-positioned to support Chromodynamics with our expertise in building successful companies and leveraging our network in the biotech industry,".

Wouter Vijvers said, “I want to live in a world where treatments are kinder to the patient, but harsher on the disease, and known to work for each unique individual before being administered. With the support of KIKK Capital, we have taken a big step towards the launch of a product that brings us closer to that future. And that is what drives our talented team to great heights.”

About Chromodynamics

Founded in 2019, Chromodynamics aims to remove uncertainty from drug development and prescriptions. The company develops advanced microscopy products using hyperspectral imaging technology. Based at the High Tech Campus in Eindhoven, it is working on launching an automated microscope platform that can identify cells in tissue samples on its own.